Affordable and Equitable Cancer Care: a global right

Affordable and Equitable Cancer Care: a global right

In 2011 the ICP led the first major commission looking at delivering affordable cancer in high income countries.

http://www.thelancet.com/commissions/delivering-affordable-cancer-care-in-high-income-countries

This was followed by the first populations estimates of economic impact of cancer in Europe from both a direct and productivity loss perspective.

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70442-X/abstract

Most recently the ICP with the Lancet Oncology and the Journal of Cancer Policy led a three year on study of solutions to the cost of cancer.

http://www.thelancet.com/series/affordable-cancer-care

http://www.journals.elsevier.com/journal-of-cancer-policy/recent-articles/

We are currently engaged in studying the role of behavioral economics, particularly ‘nudge’ policies, various global taskforces on ‘affordable cancer care’ including ESMO Clinical Benefits Scale project.

http://www.esmo.org/content/download/16414/287782/file/ESMO-Clinical-Benefit-Scale.pdf

The ICP is also engaging in programs around the issues of delivering affordable care in emerging economies, particularly India. From 2015 the ICP will be launching a a new program in behavioural economics in cancer focusing on choice and health systems

Partners

Heath Economics Research Centre, Oxford
Lancet Oncology
ESMO

Related Projects
#
Projects
The evolution of personalised cancer medicine: hype or hope?
#
Projects
Economic impact of ageing & cancer - State of R&D relevant…
#
Projects